Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease-Reference-Cited by-同舟云学术

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease

Published:2019-12-11 Issue:12 Volume:2 Page:e1917126
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Llibre-Guerra Jorge J.¹,Li Yan²,Schindler Suzanne E.¹,Gordon Brian A.³,Fagan Anne M.¹⁴,Morris John C.¹⁵⁶,Benzinger Tammie L. S.³,Hassenstab Jason¹,Wang Guoqiao⁷,Allegri Ricardo⁸,Berman Sarah B.³⁹,Chhatwal Jasmeer¹⁰,Farlow Martin R.¹¹,Holtzman David M.¹⁵⁶,Jucker Mathias⁷¹²,Levin Johannes¹³¹⁴¹⁵,Noble James M.¹⁶,Salloway Stephen¹⁷,Schofield Peter¹⁸¹⁹,Karch Celeste²⁰,Fox Nick C.²¹,Xiong Chengjie²,Bateman Randall J.¹,McDade Eric¹

Affiliation:

1. Department of Neurology, Washington University in St Louis, St Louis, Missouri

2. Department of Biostatistics, Washington University in St Louis, St Louis, Missouri

3. Department of Radiology, Washington University in St Louis, St Louis, Missouri

4. Department of Pathology and Immunology, Washington University School of Medicine in St Louis, St Louis, Missouri

5. Hope Center for Neurological Disorders, St Louis, Missouri

6. Knight Alzheimer’s Disease Research Center, St Louis, Missouri

7. Hertie Institute for Clinical Brain Research, Department of Cellular Neurology, University of Tübingen, Tübingen, Germany

8. Department of Cognitive Neurology, Institute for Neurological Research Fleni, Buenos Aires, Argentina

9. Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania

10. Massachusetts General Hospital, Harvard Medical School, Boston

11. Neuroscience Center, Indiana University, Bloomington

12. DZNE-German Center for Neurodegenerative Diseases, Tübingen, Tübingen, Germany

13. Department of Neurology, Ludwig-Maximilians-University, Munich, Germany

14. DZNE-German Center for Neurodegenerative Diseases, Munich, Munich, Germany

15. SyNergy, Munich Cluster for Systems Neurology, Munich, Germany

16. Taub Institute for Research on Alzheimer’s Disease, Aging Brain G.H. Sergievsky Center, Department of Neurology, Columbia University Medical Center, New York, New York

17. Memory & Aging Program, Butler Hospital, Brown University, Providence, Rhode Island

18. Neuroscience Research Australia, Randwick, Sydney, New South Wales, Australia

19. School of Medical Sciences, UNSW Sydney, Sydney, New South Wales, Australia

20. Department of Psychiatry, Washington University in St Louis, St Louis, Missouri

21. Dementia Research Centre, University College London, London, United Kingdom

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2757369/llibreguerra_2019_oi_190648.pdf

Reference57 articles.

1. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.;Braak;J Neuropathol Exp Neurol,2011

2. National Institute on Aging: Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease.;Hyman;Alzheimers Dement,2012

3. CSF biomarkers for the differential diagnosis of Alzheimer’s disease: a large-scale international multicenter study.;Ewers;Alzheimers Dement,2015

4. Revolutionizing Alzheimer’s disease and clinical trials through biomarkers.;Mattsson;Alzheimers Dement (Amst),2015

5. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.;Sperling;Alzheimers Dement,2011

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

2. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-02

3. Longitudinal Relationship Between Brain Atrophy Patterns, Cognitive Decline, and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Explored by Orthonormal Projective Non-Negative Matrix Factorization;Journal of Alzheimer's Disease;2024-04-02

4. Association of CSF biomarkers with MRI brain changes in Alzheimer's disease;Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring;2024-01

5. Cerebrospinal Fluid Alzheimer’s Disease Biomarker Patterns of Change Prior to the Onset of Mild Cognitive Impairment;Journal of Alzheimer's Disease;2023-10-24